A detailed history of Aviso Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aviso Wealth Management holds 1,620 shares of REGN stock, worth $1.32 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
1,620
Previous 1,645 1.52%
Holding current value
$1.32 Million
Previous $1.73 Billion 1.5%
% of portfolio
0.92%
Previous 1.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1024.09 - $1201.76 $25,602 - $30,044
-25 Reduced 1.52%
1,620 $1.7 Billion
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $318,835 - $386,699
361 Added 28.12%
1,645 $1.73 Billion
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $377,324 - $415,220
418 Added 48.27%
1,284 $1.24 Billion
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $671,305 - $763,552
866 New
866 $761 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $87.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Aviso Wealth Management Portfolio

Follow Aviso Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aviso Wealth Management with notifications on news.